mda-mb-468 glutathione content Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers Frontiers | Formononetin triggers ferroptosis

Frontiers Formononetin triggers ferroptosis in triple negative breast cancer cells by regulating the mTORC1 SREBP1 SCD1 pathway Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports Auranofin Suppresses Cancer Cell Invasion by Inhibiting Heparanase 1 Expression via the aPKCNF B Pathway Gankyrin inhibits ferroptosis through the p53 SLC7A11 GPX4 axis in triple negative breast cancer cells Scientific Reports

SKU: 7606676844 · From trustt.digital